Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.

January 18, 2021
Open Access

Clearance of intracellular tau protein from neuronal cells via VAMP8-induced secretion

The Journal of Biological Chemistry
Julie PilliodNicole Leclerc
January 19, 2021

Seeding-Competent Tau in Gray Matter Versus White Matter of Alzheimer's Disease Brain

Journal of Alzheimer's Disease : JAD
Ruozhen WuFei Liu
January 20, 2021

Facile Installation of Post-translational Modifications on the Tau Protein via Chemical Mutagenesis

ACS Chemical Neuroscience
Philip R LindstedtMichele Vendruscolo
January 19, 2021

Alzheimer's Disease, Neural Plasticity, and Functional Recovery

Journal of Alzheimer's Disease : JAD
Daymara Mercerón-MartínezAdrian G Palacios
January 17, 2021

Interplay between tau and α-synuclein LLPS

Protein Science : a Publication of the Protein Society
Anna SiegertMarkus Zweckstetter
January 20, 2021

Indication of retrograde tau spreading along Braak stages and functional connectivity pathways

European Journal of Nuclear Medicine and Molecular Imaging
Joseph Seemillerand the Alzheimer’s Disease Neuroimaging Initiative
January 20, 2021

Molecular Imaging Approaches in Dementia

Victor L VillemagneBart N M van Berckel
January 16, 2021
Open Access

Spatial memory deficiency early in 6xTg Alzheimer's disease mouse model

Scientific Reports
Shinwoo KangKeun-A Chang
January 18, 2021

Inflammation and Parkinson's disease pathogenesis: Mechanisms and therapeutic insight

Progress in Molecular Biology and Translational Science
Gianluigi ForloniClaudia Balducci
January 18, 2021

The cellular machinery of post-endocytic APP trafficking in Alzheimer's disease: A future target for therapeutic intervention?

Progress in Molecular Biology and Translational Science
Lawrence S B Goldstein, Utpal Das
January 15, 2021

Evaluating Alzheimer Disease With Flortaucipir and Florbetapir PET: A Clinical Case Series

Clinical Nuclear Medicine
Olga G JamesTerence Z Wong
January 16, 2021

Multi-Targeting Tacrine Conjugates with Cholinesterase and Amyloid-Beta Inhibitory Activities: New Anti-Alzheimer's Agents

Chemistry & Biodiversity
Asha HiremathadRangappa S Keri
January 19, 2021

GSK-3 Inhibitors: A new class of drugs for Alzheimer's Disease Treatment

Current Drug Targets
Dilipkumar PalSatish Balasaheb Nimse
January 15, 2021

Crocus sativus L. (Saffron) in Alzheimer's disease treatment: bioactive effects on cognitive impairment

Current Neuropharmacology
Grazia D'OnofrioStefano Pieretti
January 19, 2021

Tau in the Pathophysiology of Parkinson's Disease

Journal of Molecular Neuroscience : MN
Lina PanZhentao Zhang

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.


TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2021 Meta ULC. All rights reserved